141 related articles for article (PubMed ID: 3987181)
1. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
Vozeh S; Uematsu T; Guentert TW; Ha HR; Follath F
Clin Pharmacol Ther; 1985 May; 37(5):575-81. PubMed ID: 3987181
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
Ha HR; Vozeh S; Uematsu T; Guentert TW; Follath F
Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administration.
Lecocq B; Jaillon P; Lecocq V; Ferry A; Gardin ME; Jarreau C; Leroyer R; Pays M; Jarreau FX
J Cardiovasc Pharmacol; 1988 Oct; 12(4):445-50. PubMed ID: 2465445
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion kinetics of intact quinidine and 3-OH-quinidine after oral administration of a single oral dose of quinidine gluconate in the fasting and non-fasting state.
St-Onge JM; Sirois G; Gagnon MA
Eur J Drug Metab Pharmacokinet; 1983; 8(4):363-72. PubMed ID: 6673973
[TBL] [Abstract][Full Text] [Related]
7. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.
Holford NH; Coates PE; Guentert TW; Riegelman S; Sheiner LB
Br J Clin Pharmacol; 1981 Feb; 11(2):187-95. PubMed ID: 7213522
[TBL] [Abstract][Full Text] [Related]
8. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
Camsonne R; Moulin MA; Charbonneau P; Bazin C
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
[TBL] [Abstract][Full Text] [Related]
9. Method for stable measurement of the electrocardiogram in isolated guinea pig heart. Evaluation of the RR-QT relationship and the effect of quinidine.
Uematsu T; Vozeh S; Ha HR; Follath F; Nakashima M
J Pharmacol Methods; 1987 Sep; 18(2):179-85. PubMed ID: 3626572
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of quinidine and three of its metabolites in man.
Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
[TBL] [Abstract][Full Text] [Related]
11. Relative electrophysiological potencies of quinidine, 3-OH quinidine and quinidine-N-oxide in guinea-pig heart.
Uematsu T; Sato R; Vozeh S; Follath F; Nakashima M
Arch Int Pharmacodyn Ther; 1989; 297():29-38. PubMed ID: 2730239
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
Vozeh S; Oti-Amoako K; Uematsu T; Follath F
J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
[TBL] [Abstract][Full Text] [Related]
13. Greater quinidine-induced QTc interval prolongation in women.
Benton RE; Sale M; Flockhart DA; Woosley RL
Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
[TBL] [Abstract][Full Text] [Related]
14. Rapid elimination of quinidine in pediatric patients.
Szefler SJ; Pieroni DR; Gingell RL; Shen DD
Pediatrics; 1982 Sep; 70(3):370-5. PubMed ID: 7110810
[TBL] [Abstract][Full Text] [Related]
15. Effects of quinidine on pharmacokinetics and pharmacodynamics of digitoxin achieving steady-state conditions.
Kuhlmann J; Dohrmann M; Marcin S
Clin Pharmacol Ther; 1986 Mar; 39(3):288-94. PubMed ID: 3512148
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the pharmacokinetic and pharmacodynamic interaction between quinidine and nifedipine.
Bowles SK; Reeves RA; Cardozo L; Edwards DJ
J Clin Pharmacol; 1993 Aug; 33(8):727-31. PubMed ID: 8408733
[TBL] [Abstract][Full Text] [Related]
17. Disposition kinetics of quinidine.
Ueda CT; Hirschfeld DS; Scheinman MM; Rowland M; Williamson BJ; Dzindzio BS
Clin Pharmacol Ther; 1976 Jan; 19(1):30-6. PubMed ID: 1245091
[TBL] [Abstract][Full Text] [Related]
18. Assessment of quinidine gluconate for nonlinear kinetics following chronic dosing.
Russo J; Russo ME; Smith RA; Pershing LK
J Clin Pharmacol; 1982; 22(5-6):264-70. PubMed ID: 7107973
[TBL] [Abstract][Full Text] [Related]
19. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine.
Hardy BG; Zador IT; Golden L; Lalka D; Schentag JJ
Am J Cardiol; 1983 Jul; 52(1):172-5. PubMed ID: 6858908
[TBL] [Abstract][Full Text] [Related]
20. Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects.
Baker BJ; Gammill J; Massengill J; Schubert E; Karin A; Doherty JE
Am Heart J; 1983 Jan; 105(1):12-5. PubMed ID: 6849225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
